Jenna D. Goldberg
Oncode Institute(NL)Janssen (United States)(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, CAR-T cell therapy research, Renal Transplantation Outcomes and Treatments, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease(2015)752 cited
- → Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma(2022)599 cited
- → Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research(2014)433 cited
- → Clinical applications of palifermin: amelioration of oral mucositis and other potential indications(2013)63 cited
- → Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant(2017)61 cited
- → T Cell–Depleted Stem Cell Transplantation for Adults with High-Risk Acute Lymphoblastic Leukemia: Long-Term Survival for Patients in First Complete Remission with a Decreased Risk of Graft-versus-Host Disease(2012)44 cited
- → Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study(2022)42 cited
- → Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study(2022)15 cited
- → T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies(2017)13 cited
- → The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS(2013)5 cited